The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Volha Lazuka

Visiting research fellow

Default user image.

Infant Health and Later-Life Labour Market Outcomes: Evidence from the Introduction of Sulpha Antibiotics in Sweden

Author

  • Volha Lazuka

Summary, in English

This paper studies the effects of improvements in infant health produced by the introduction of sulphapyridine in the late-1930s as treatment against pneumonia on outcomes in adulthood. Based on longitudinal individual data for the whole population of Sweden 1968–2012 and archival data on the availability of sulphapyridine and applying a difference-in-differences approach, it finds that mitigation of pneumonia infection in infancy increased labour income in late adulthood by 2.8–5.3 percent. The beneficial effects are strong for health, measured by length of stay in hospital, and weaker for years of schooling. These effects are similar between men and women.

Department/s

  • Department of Economic History
  • Centre for Economic Demography

Publishing year

2020

Language

English

Publication/Series

Journal of Human Resources

Volume

55

Issue

2

Document type

Journal article

Publisher

University of Wisconsin Press

Topic

  • Economic History

Keywords

  • sulpha antibiotics, early-life, infancy, labour income, human capital, Sweden

Status

Published

ISBN/ISSN/Other

  • ISSN: 0022-166X